| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17c6c7da627b7bead7208250127b52c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a893ee8991b98f85c44023d0aacd9324 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-24 |
| filingDate |
2011-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e50713f4ce40ebe53b4153888d7d447b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a1fd0c5898be5b458adec2b501e8c03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fea50dd3eb54a00e64e55b230d50f66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08df4d8e0b59b0a196adec0bf7844f90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_620811a42cf0a4f3ab2aa9cfa72c8142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bec3e0519d5cb8c6204c570ce78d43e7 |
| publicationDate |
2013-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20130024461-A |
| titleOfInvention |
Method for preparing a platycodine D derivative bioconverted with a coenzyme solution derived from Aspergillus niger and pharmaceutical composition for the prevention and treatment of hepatitis C comprising the same |
| abstract |
The present invention relates to Aspergillus niger producing dehydrogenase. niger ) to convert Platycodin D, one of the main saponins of the bellflower into 16-oxo-platicodine D, and an antiviral pharmaceutical composition comprising the compound as an active ingredient. . The derivative 16-oxo-platicodine D of the present invention is excellent in inhibiting the proliferation of hepatitis C virus (HCV) and has a low toxicity, and thus can be usefully used as a hepatitis C prevention and treatment agent. Can be. |
| priorityDate |
2011-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |